These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 9471658)

  • 1. [Screening of cervical cancer, false negative vaginal smears].
    Weintraub D
    Rev Med Suisse Romande; 1997 Nov; 117(11):921. PubMed ID: 9471658
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cervical cancer screening. False negative smears].
    Vassilakos P; De Marval F; Muñoz M
    Rev Med Suisse Romande; 1997 Aug; 117(8):597-601. PubMed ID: 9340714
    [No Abstract]   [Full Text] [Related]  

  • 3. The pitfalls of cervical cancer screening.
    Sedlis A
    Contrib Gynecol Obstet; 1991; 18():103-14. PubMed ID: 1657521
    [No Abstract]   [Full Text] [Related]  

  • 4. [Screening of cervical cancer, false negative smears].
    Vassilakos P; de Marval F; Muñoz M
    Rev Med Suisse Romande; 1998 Jan; 118(1):97. PubMed ID: 9580199
    [No Abstract]   [Full Text] [Related]  

  • 5. Pitfalls in the screening and early diagnosis of cervical cancer.
    Wain GV; Hacker NF
    Curr Opin Obstet Gynecol; 1990 Feb; 2(1):74-9. PubMed ID: 2102310
    [No Abstract]   [Full Text] [Related]  

  • 6. [Partial re-screening of all negative smears. A method of quality control of pathology department concerning smear screening against cervix cancer].
    Jensen ML; Dybdahl H; Svanholm H
    Ugeskr Laeger; 2000 May; 162(21):3024-7. PubMed ID: 10850190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pap smear refined.
    Oncology (Williston Park); 1997 Aug; 11(8):1125. PubMed ID: 9268975
    [No Abstract]   [Full Text] [Related]  

  • 8. [Significance of sources of error and quality control in cytologic mass screening].
    Zimmer S; Krahnert U; Munck C
    Zentralbl Gynakol; 1987; 109(4):209-17. PubMed ID: 3591056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [False negative Pap smears in a Danish material].
    Ejersbo D; Dahl MB; Hølund B
    Ugeskr Laeger; 2003 Jun; 165(23):2391-4. PubMed ID: 12840998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plea for quality cytological specimens in the screening of cervical cancer].
    Marie G; Barjot P; Crouet H; von Theobald P; Soutif C; Levy G
    Rev Fr Gynecol Obstet; 1993 Jun; 88(6):365-7. PubMed ID: 8351458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common problems in Papanicolaou smear interpretation.
    DeMay RM
    Arch Pathol Lab Med; 1997 Mar; 121(3):229-38. PubMed ID: 9111106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Report of a national workshop on screening for cancer of the cervix.
    Anderson GH
    CMAJ; 1992 Apr; 146(8):1280; author reply 1280, 1284-5. PubMed ID: 1555154
    [No Abstract]   [Full Text] [Related]  

  • 13. [The impending loss of screening for cervix uteri carcinoma in the Netherlands].
    Lammes FB
    Ned Tijdschr Geneeskd; 1986 Apr; 130(15):673-4. PubMed ID: 3703044
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of PAPNET--a semiautomated system used in the screening against cervical cancer].
    Hølund B; Ejersbo D; Hjortebjerg A
    Ugeskr Laeger; 1998 Sep; 160(40):5802-6. PubMed ID: 9782761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical cancer control--Rhode Island.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1989 Sep; 38(38):659-62. PubMed ID: 2506415
    [No Abstract]   [Full Text] [Related]  

  • 16. Quality assurance in cervical cytopathology.
    Light AM
    Cytopathology; 1997 Aug; 8(4):290-2. PubMed ID: 9252748
    [No Abstract]   [Full Text] [Related]  

  • 17. Rapid pre-screening of cervical smears as a method of internal quality control in a cervical screening programme.
    Tavares SB; de Sousa NL; Manrique EJ; de Albuquerque ZB; Zeferino LC; Amaral RG
    Cytopathology; 2008 Aug; 19(4):254-9. PubMed ID: 18476988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papanicolaou Society of Cytopathology guidelines for educational notes, disclaimers, and similar comments on reports of cervical cytology specimens.
    Papanicolau Society of Cytopathology Practice Guidelines Task Force
    Diagn Cytopathol; 2003 May; 28(5):282-5. PubMed ID: 12722126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European Guidelines for Quality Assurance in Cervical Cancer Screening. Europe against cancer programme.
    Coleman D; Day N; Douglas G; Farmery E; Lynge E; Philip J; Segnan N
    Eur J Cancer; 1993; 29A Suppl 4():S1-38. PubMed ID: 8274301
    [No Abstract]   [Full Text] [Related]  

  • 20. [A reply on cervix cancer screening: cervical cytological test doesn't fulfil the requirements of a good screening test].
    Bistoletti P
    Lakartidningen; 2000 Sep; 97(37):4042. PubMed ID: 11036367
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.